Apoptosis and
inflammation play an important role in the pathogenesis of direct/pulmonary
acute lung injury (ALI). However, the role of the
Fas receptor-driven apoptotic pathway in indirect/nonpulmonary ALI is virtually unstudied. We hypothesized that if Fas or
caspase-8 plays a role in the induction of indirect ALI, their local silencing using
small interfering RNA (
siRNA) should be protective in
hemorrhage-induced septic ALI. Initially, as a proof of principle,
green fluorescent protein-
siRNA was administered intratracheally into transgenic mice overexpressing
green fluorescent protein. Twenty-four hours after
siRNA delivery, lung sections revealed a significant decrease in green fluorescence. Intratracheally administered Cy-5-labeled Fas-
siRNA localized primarily in pulmonary epithelial cells. Intratracheal instillation of
siRNA did not induce
lung inflammation via
toll-like receptor or
protein kinase PKR pathways as assessed by lung tissue
interferon-alpha,
tumor necrosis factor-alpha, and
interleukin (IL)-6 levels. Mice subjected to
hemorrhagic shock and
sepsis received either Fas-, caspase-8-, or control-
siRNA intratracheally 4 hours after
hemorrhage. Fas- or caspase-8-siRNA significantly reduced lung tissue Fas or
caspase-8 mRNA, respectively. Only Fas-
siRNA markedly diminished lung tissue
tumor necrosis factor-alpha,
IL-6,
IL-10,
interferon-gamma,
IL-12, and
caspase-3 activity. Fas-
siRNA also preserved alveolar architecture and reduced lung neutrophil infiltration and pulmonary epithelial apoptosis. These data indicate the pathophysiological significance of Fas activation in nonpulmonary/
shock-induced ALI and the feasibility of intrapulmonary administration of anti-apoptotic
siRNA in vivo.